REGEMAT 3D

Regemat3d, a Spain-based startup founded in 2019, specializes in developing Customized Bioprinting systems and Bioreactors (BMAP) for the biotechnology and manufacturing industries. The company's slogan, "Customized Bioprinting systems and Bioreactors," reflects its core focus on creating living tissue technologies. The potential of bioprinting in regenerative medicine and tissue engineering is immense, and Regemat3d aims to address the many challenges and hypotheses associated with tissue regeneration. The company's mission is to develop innovative solutions in the field of bioprinting and regenerative medicine, with the ultimate goal of clinically applying this groundbreaking technology to enhance people's quality of life. In March 2022, Regemat3d attracted a significant investment of €515.57K through equity crowdfunding, with Crowdcube participating as the lead investor. This investment not only demonstrates confidence in Regemat3d's potential but also signifies the growing interest in bioprinting and regenerative medicine within the investment community.